Ishida T, Ito S, Tanaka J, Uchiyama M, Kawano Y, Moreau P, Martin T, Risse ML, Tada K, Suzuki K, Ishizawa K.

Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomised, open label, phase 3 IKEMA study.

Jpn J Clin Oncol 52(12):1446-1449,2022.doi: 10.1093/jjco/hyac137.

https://pubmed.ncbi.nlm.nih.gov/36073950/